These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33420682)

  • 1. Number of Antithrombotic Drugs Used Early and In-hospital Outcomes in Acute Coronary Syndromes.
    Martín-Asenjo R; Gregson J; Rossello X; Van de Werf F; Medina J; Danchin N; Pocock S; Bueno H
    J Cardiovasc Transl Res; 2021 Aug; 14(4):790-798. PubMed ID: 33420682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Outcome of Acute Coronary Syndromes in Patients on Chronic Oral Anticoagulants: Data from the EPICOR Study.
    Stepinska J; Wojtkowska I; Annemans L; Danchin N; Pocock SJ; de Werf FV; Medina J; Bueno H
    Curr Vasc Pharmacol; 2020; 18(1):92-99. PubMed ID: 30588886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale, Design, and Baseline Characteristics of the EPICOR Asia Study (Long-tErm follow-uP of antithrombotic management patterns In Acute CORonary Syndrome patients in Asia).
    Huo Y; Lee SW; Sawhney JP; Kim HS; Krittayaphong R; Nhan VT; Alonso-Garcia A; Han YL; Ge J; Chin CT; Ong TK; Jan S; Itoh Y; Vega AM; Pocock S
    Clin Cardiol; 2015 Sep; 38(9):511-9. PubMed ID: 26206158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended dual antiplatelet therapy after acute coronary syndrome in Spain: Results from the EPICOR study.
    Bardají A; Leal M; Arrarte V; Garcia-Moll X; Pérez de Isla L; Bueno H
    Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 27885830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry.
    Zeymer U; Annemans L; Danchin N; Pocock S; Newsome S; Van de Werf F; Medina J; Bueno H
    Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):121-129. PubMed ID: 29611427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EPICOR (long-tErm follow-up of antithrombotic management Patterns In acute CORonary syndrome patients) study: rationale, design, and baseline characteristics.
    Bueno H; Danchin N; Tafalla M; Bernaud C; Annemans L; Van de Werf F
    Am Heart J; 2013 Jan; 165(1):8-14. PubMed ID: 23237128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Antithrombotic Therapy and Clinical Outcomes in Patients with Acute Coronary Syndrome and Renal Impairment: Insights from EPICOR and EPICOR Asia.
    Huo Y; Van de Werf F; Han Y; Rossello X; Pocock SJ; Chin CT; Lee SW; Li Y; Jiang J; Vega AM; Medina J; Bueno H
    Am J Cardiovasc Drugs; 2021 Jul; 21(4):471-482. PubMed ID: 33537947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term antithrombotic management patterns in Asian patients with acute coronary syndrome: 2-year observations from the EPICOR Asia study.
    Zheng B; Huo Y; Lee SW; Sawhney JPS; Kim HS; Krittayaphong R; Pocock SJ; Nhan VT; Alonso Garcia A; Chin CT; Jiang J; Jan S; Vega AM; Hayashi N; Ong TK
    Clin Cardiol; 2020 Sep; 43(9):999-1008. PubMed ID: 32618009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current patterns of antithrombotic and revascularisation therapy in patients hospitalised for acute coronary syndromes. Data from the Polish subset of the EPICOR study.
    Wojtkowska I; Stępińska J; Stępień-Wojno M; Sobota M; Kopaczewski J; Reszka Z; Kurzelewski M; Medina J
    Kardiol Pol; 2017; 75(5):445-452. PubMed ID: 28281731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term follow-up of antithrombotic management patterns in patients hospitalized with acute coronary syndrome: Indian subgroup of EPICOR Asia study.
    Sawhney JPS; Mullasari A; Kahali D; Mehta V; Nair T; Kaul U; Hirematth MS
    Indian Heart J; 2019; 71(1):25-31. PubMed ID: 31000179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
    Windecker S; Lopes RD; Massaro T; Jones-Burton C; Granger CB; Aronson R; Heizer G; Goodman SG; Darius H; Jones WS; Aschermann M; Brieger D; Cura F; Engstrøm T; Fridrich V; Halvorsen S; Huber K; Kang HJ; Leiva-Pons JL; Lewis BS; Malaga G; Meneveau N; Merkely B; Milicic D; Morais J; Potpara TS; Raev D; Sabaté M; de Waha-Thiele S; Welsh RC; Xavier D; Mehran R; Alexander JH;
    Circulation; 2019 Dec; 140(23):1921-1932. PubMed ID: 31557056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary inter-hospital transfer patterns for the management of acute coronary syndrome patients: findings from the EPICOR study.
    Sinnaeve PR; Zeymer U; Bueno H; Danchin N; Medina J; Sánchez-Covisa J; Licour M; Annemans L; Jukema JW; Pocock S; Storey RF; Van de Werf F
    Eur Heart J Acute Cardiovasc Care; 2015 Jun; 4(3):254-62. PubMed ID: 25210075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time trends in antithrombotic management of patients with atrial fibrillation treated with coronary stents: Results from TALENT-AF (The internAtionaL stENT - Atrial Fibrillation study) multicenter registry.
    Potter BJ; Andò G; Cimmino G; Ladeiras-Lopes R; Frikah Z; Chen XY; Virga V; Goncalves-Almeida J; Camm AJ; Fox KAA
    Clin Cardiol; 2018 Apr; 41(4):470-475. PubMed ID: 29663443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International patterns of dual antiplatelet therapy duration after acute coronary syndromes.
    Bueno H; Pocock S; Danchin N; Annemans L; Gregson J; Medina J; Van de Werf F
    Heart; 2017 Jan; 103(2):132-138. PubMed ID: 27504002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding After Hospital Discharge Following Acute Coronary Syndrome: Incidence, Types, Timing, and Predictors.
    Ismail N; Jordan KP; Kadam UT; Edwards JJ; Kinnaird T; Mamas MA
    J Am Heart Assoc; 2019 Nov; 8(21):e013679. PubMed ID: 31657257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-trends and treatment gaps in the antithrombotic management of patients with atrial fibrillation after percutaneous coronary intervention: Insights from the CHUM AF-STENT Registry.
    Boivin-Proulx LA; Deneault-Marchand A; Matteau A; Mansour S; Gobeil F; Camm JA; Fox KAA; Potter BJ
    Clin Cardiol; 2020 Mar; 43(3):216-221. PubMed ID: 31850592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding Events Before Coronary Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.
    Redfors B; Kirtane AJ; Pocock SJ; Ayele GM; Deliargyris EN; Mehran R; Stone GW; Généreux P
    J Am Coll Cardiol; 2016 Dec; 68(24):2608-2618. PubMed ID: 27978944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic strategies and outcomes in acute coronary syndrome with atrial fibrillation.
    Chamberlain AM; Gersh BJ; Mills RM; Klaskala W; Alonso A; Weston SA; Roger VL
    Am J Cardiol; 2015 Apr; 115(8):1042-8. PubMed ID: 25726381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current antithrombotic agents for acute coronary syndromes: focus on bleeding risk.
    Bassand JP
    Int J Cardiol; 2013 Feb; 163(1):5-18. PubMed ID: 22100180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guideline-adherent therapy in patients with acute coronary syndromes. The EPICOR registry in Germany.
    Zeymer U; Heuer H; Schwimmbeck P; Genth-Zotz S; Wolff K; Nienaber CA;
    Herz; 2015 Mar; 40 Suppl 1():27-35. PubMed ID: 25374386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.